Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Decitabine attenuates nociceptive behavior in a murine model of bone cancer pain.

Appel CK, Scheff NN, Viet CT, Schmidt BL, Heegaard AM.

Pain. 2019 Mar;160(3):619-631. doi: 10.1097/j.pain.0000000000001442.

PMID:
30422869
2.

Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.

Ye Y, Scheff NN, Bernabé D, Salvo E, Ono K, Liu C, Veeramachaneni R, Viet CT, Viet DT, Dolan JC, Schmidt BL.

Neuropharmacology. 2018 Sep 1;139:182-193. doi: 10.1016/j.neuropharm.2018.07.016. Epub 2018 Jul 20.

PMID:
30009833
3.

Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling.

Ono K, Viet CT, Ye Y, Dang D, Hitomi S, Toyono T, Inenaga K, Dolan JC, Schmidt BL.

Sci Rep. 2017 Aug 23;7(1):9181. doi: 10.1038/s41598-017-09682-4.

4.

Alterations in opioid inhibition cause widespread nociception but do not affect anxiety-like behavior in oral cancer mice.

Ye Y, Bernabé DG, Salvo E, Viet CT, Ono K, Dolan JC, Janal M, Aouizerat BE, Miaskowski C, Schmidt BL.

Neuroscience. 2017 Nov 5;363:50-61. doi: 10.1016/j.neuroscience.2017.06.038. Epub 2017 Jun 30.

PMID:
28673713
5.

OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.

Viet CT, Dang D, Aouizerat BE, Miaskowski C, Ye Y, Viet DT, Ono K, Schmidt BL.

J Pain. 2017 Sep;18(9):1046-1059. doi: 10.1016/j.jpain.2017.04.001. Epub 2017 Apr 27.

6.

Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.

Yamano S, Viet CT, Dang D, Dai J, Hanatani S, Takayama T, Kasai H, Imamura K, Campbell R, Ye Y, Dolan JC, Kwon WM, Schneider SD, Schmidt BL.

Pain. 2017 Feb;158(2):240-251. doi: 10.1097/j.pain.0000000000000750.

7.

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.

Peterson DE, O'Shaughnessy JA, Rugo HS, Elad S, Schubert MM, Viet CT, Campbell-Baird C, Hronek J, Seery V, Divers J, Glaspy J, Schmidt BL, Meiller TF.

Cancer Med. 2016 Aug;5(8):1897-907. doi: 10.1002/cam4.761. Epub 2016 Jun 23. Review.

8.

RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers.

Hallums DP, Gomez R, Doyle AP, Viet CT, Schmidt BL, Jeske NA.

Clin Surg. 2016;1. pii: 1100. Epub 2016 Sep 1.

9.

Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.

Samoshkin A, Convertino M, Viet CT, Wieskopf JS, Kambur O, Marcovitz J, Patel P, Stone LS, Kalso E, Mogil JS, Schmidt BL, Maixner W, Dokholyan NV, Diatchenko L.

Sci Rep. 2015 Dec 11;5:18198. doi: 10.1038/srep18198.

10.

Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.

Convertino M, Samoshkin A, Viet CT, Gauthier J, Li Fraine SP, Sharif-Naeini R, Schmidt BL, Maixner W, Diatchenko L, Dokholyan NV.

PLoS One. 2015 Nov 10;10(11):e0142826. doi: 10.1371/journal.pone.0142826. eCollection 2015.

11.

TRPV1 expression level in isolectin B₄-positive neurons contributes to mouse strain difference in cutaneous thermal nociceptive sensitivity.

Ono K, Ye Y, Viet CT, Dang D, Schmidt BL.

J Neurophysiol. 2015 May 1;113(9):3345-55. doi: 10.1152/jn.00973.2014. Epub 2015 Mar 18.

12.

Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma.

Viet CT, Dang D, Achdjian S, Ye Y, Katz SG, Schmidt BL.

PLoS One. 2014 Nov 12;9(11):e112880. doi: 10.1371/journal.pone.0112880. eCollection 2014.

13.

Demethylating drugs as novel analgesics for cancer pain.

Viet CT, Dang D, Ye Y, Ono K, Campbell RR, Schmidt BL.

Clin Cancer Res. 2014 Sep 15;20(18):4882-4893. doi: 10.1158/1078-0432.CCR-14-0901. Epub 2014 Jun 24.

14.

Review of preclinical studies on treatment of mucositis and associated pain.

Viet CT, Corby PM, Akinwande A, Schmidt BL.

J Dent Res. 2014 Sep;93(9):868-75. doi: 10.1177/0022034514540174. Epub 2014 Jun 18. Review.

15.

Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers.

Ye Y, Ono K, Bernabé DG, Viet CT, Pickering V, Dolan JC, Hardt M, Ford AP, Schmidt BL.

Acta Neuropathol Commun. 2014 Jun 5;2:62. doi: 10.1186/2051-5960-2-62.

16.

IB4(+) and TRPV1(+) sensory neurons mediate pain but not proliferation in a mouse model of squamous cell carcinoma.

Ye Y, Bae SS, Viet CT, Troob S, Bernabé D, Schmidt BL.

Behav Brain Funct. 2014 Feb 13;10:5. doi: 10.1186/1744-9081-10-5.

17.

Analgesia targeting IB4-positive neurons in cancer-induced mechanical hypersensitivity.

Ye Y, Dang D, Viet CT, Dolan JC, Schmidt BL.

J Pain. 2012 Jun;13(6):524-31. doi: 10.1016/j.jpain.2012.01.006. Epub 2012 Apr 5.

18.

Biologic mechanisms of oral cancer pain and implications for clinical therapy.

Viet CT, Schmidt BL.

J Dent Res. 2012 May;91(5):447-53. doi: 10.1177/0022034511424156. Epub 2011 Oct 4. Review.

19.

Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.

Viet CT, Ye Y, Dang D, Lam DK, Achdjian S, Zhang J, Schmidt BL.

Pain. 2011 Oct;152(10):2323-32. doi: 10.1016/j.pain.2011.06.025. Epub 2011 Jul 22.

20.

Nerve growth factor links oral cancer progression, pain, and cachexia.

Ye Y, Dang D, Zhang J, Viet CT, Lam DK, Dolan JC, Gibbs JL, Schmidt BL.

Mol Cancer Ther. 2011 Sep;10(9):1667-76. doi: 10.1158/1535-7163.MCT-11-0123. Epub 2011 Jul 12.

21.

Understanding oral cancer in the genome era.

Viet CT, Schmidt BL.

Head Neck. 2010 Sep;32(9):1246-68. doi: 10.1002/hed.21358. Review.

PMID:
20187013
22.

Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients.

Viet CT, Schmidt BL.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3603-11. doi: 10.1158/1055-9965.EPI-08-0507.

23.

DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer.

Viet CT, Jordan RC, Schmidt BL.

J Calif Dent Assoc. 2007 Dec;35(12):844-9.

PMID:
18240747

Supplemental Content

Support Center